Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

130 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Glial activation colocalizes with structural abnormalities in amyotrophic lateral sclerosis.
Alshikho MJ, Zürcher NR, Loggia ML, Cernasov P, Chonde DB, Izquierdo Garcia D, Yasek JE, Akeju O, Catana C, Rosen BR, Cudkowicz ME, Hooker JM, Atassi N. Alshikho MJ, et al. Among authors: atassi n. Neurology. 2016 Dec 13;87(24):2554-2561. doi: 10.1212/WNL.0000000000003427. Epub 2016 Nov 11. Neurology. 2016. PMID: 27837005 Free PMC article.
Safety and efficacy of lithium in combination with riluzole for treatment of amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled trial.
Aggarwal SP, Zinman L, Simpson E, McKinley J, Jackson KE, Pinto H, Kaufman P, Conwit RA, Schoenfeld D, Shefner J, Cudkowicz M; Northeast and Canadian Amyotrophic Lateral Sclerosis consortia. Aggarwal SP, et al. Lancet Neurol. 2010 May;9(5):481-8. doi: 10.1016/S1474-4422(10)70068-5. Epub 2010 Apr 1. Lancet Neurol. 2010. PMID: 20363190 Free PMC article. Clinical Trial.
ALSUntangled update 4: investigating the XCell-Center.
ALSUntangled Group. ALSUntangled Group. Amyotroph Lateral Scler. 2010 May 3;11(3):337-8. doi: 10.3109/17482961003755005. Amyotroph Lateral Scler. 2010. PMID: 20443222 No abstract available.
ALSUntangled No. 6: Investigating Marty Murray's method.
ALSUntangled Group. ALSUntangled Group. Amyotroph Lateral Scler. 2010 Oct;11(5):494-6. doi: 10.3109/17482968.2010.511129. Amyotroph Lateral Scler. 2010. PMID: 20839919 No abstract available.
Depression in amyotrophic lateral sclerosis.
Atassi N, Cook A, Pineda CM, Yerramilli-Rao P, Pulley D, Cudkowicz M. Atassi N, et al. Amyotroph Lateral Scler. 2011 Mar;12(2):109-12. doi: 10.3109/17482968.2010.536839. Epub 2010 Nov 24. Amyotroph Lateral Scler. 2011. PMID: 21091399 Free PMC article.
Towards a neuroimaging biomarker for amyotrophic lateral sclerosis.
Turner MR, Grosskreutz J, Kassubek J, Abrahams S, Agosta F, Benatar M, Filippi M, Goldstein LH, van den Heuvel M, Kalra S, Lulé D, Mohammadi B; first Neuroimaging Symosium in ALS (NISALS). Turner MR, et al. Lancet Neurol. 2011 May;10(5):400-3. doi: 10.1016/S1474-4422(11)70049-7. Lancet Neurol. 2011. PMID: 21511189 No abstract available.
Safety, tolerability and pharmacodynamics of a skeletal muscle activator in amyotrophic lateral sclerosis.
Shefner J, Cedarbaum JM, Cudkowicz ME, Maragakis N, Lee J, Jones D, Watson ML, Mahoney K, Chen M, Saikali K, Mao J, Russell AJ, Hansen RL, Malik F, Wolff AA; Neals/Cytokinetics Study Team. Shefner J, et al. Amyotroph Lateral Scler. 2012 Sep;13(5):430-8. doi: 10.3109/17482968.2012.684214. Epub 2012 May 16. Amyotroph Lateral Scler. 2012. PMID: 22591195 Clinical Trial.
130 results